BioAtla BCAB
OTC BCAB
$1.50 -0.10 (-6.25%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioAtla (BCAB) EBT Margin (2020 - 2026)

Updated

BioAtla's EBT Margin was 3.74% in Q2 2026.

Analysis

BioAtla (BCAB) EBT Margin (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, BioAtla's EBT Margin was -374.89% through Jun 30, 2026, up 187.80 percentage points year-over-year; for FY2025, it was -2923.10%, down 2281.52 percentage points from FY2024.

  • EBT Margin shows a five-year change of +4393.45 percentage points (FY2020 to FY2025).
  • In earlier years, EBT Margin was -641.58% in FY2024 and -38437.20% in FY2021 (-31120.65 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 26.66%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 25.18%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -4.11%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 29.63%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 18.19%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 27.53%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 41.75%
10 BioAtla 2.49 Mn 2.49 Mn - 3.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.74%
Dec 31, 2025 -459.10%
Sep 30, 2024 -96.16%
Jun 30, 2021 -12,152.40%
Sep 30, 2020 -5,380.00%
Jun 30, 2020 -2,775.26%
Mar 31, 2020 -1,855.06%
API Access

BioAtla EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=BCAB&period=max&api_key=YOUR_API_KEY